Alendronate a promising / multi aspect drug in the management of ostoeoporosis

Journal Title: Pakistan Journal of Pharmacology - Year 2011, Vol 28, Issue 1

Abstract

Recently, osteoporosis is regarded as a major health concern due to increase in its incidence, associated morbidities and mortalities. Among antiresorptives, alendronate which is a bisphosphonate is FDA (Food and Drug Administration) approved drug of choice for postmenopausal and glucorticoid induced osteoporosis. It has been also recommended for the prevention of bone loss in perimenopausal women. Currently, it has been also viewed as a treatment option in osteoporotic males. Several clinical trials have highlighted the significant role of alendronate in the management of osteoporosis. Although it was proved to be a safe drug for longer time periods but very recently some studies have reported the risk of low energy subtrochanteric and diaphyseal femoral shaft fractures in the chronic users of alendronate. The current review is undertaken to elaborate the different aspects related to this drug in the scenario of osteoporosis management.

Authors and Affiliations

Shehla Shaheen, Qamaruddin Barakzai, Syed Noor, Mansoor Khan

Keywords

Related Articles

Lead induced effects on renal alkaline phosphatase with role of zinc in albino rats

Kidneys are adversely affected by a wide variety of therapeutic agents and chemicals including the environmental pollutants such as Lead. The nephrotoxic effects of lead have been widely studied. The proximal tubular cel...

Role of alpha tocopherol as an adjuvant therapy in pregnancy induced hypertension

Hypertension is the most common medical problem encountered in pregnancy and remains an important cause of maternal and fetal morbidity and mortality. To conduct a clinical study to evaluate the adjuvant effect of alpha-...

Electrolyte changes in cigarette smoking male students

The Cigarette smoke reaches quickly to heart, brain and other parts of our body and may cause effects in less than a second as it is inhaled directly into the alveoli and is diffused into the pulmonary vein. Inspite of n...

Determination of neuron specific enolase (NSE) in small cell lung carcinoma (SCLC) and non-small cell lung carcinoma (NSCLC) patients

Neuron specific enolase (NSE) is routinely used as tumor marker in Small cell lung carcinoma (SCLC), and to some extent in non-small cell lung carcinoma (NSCLC). In Pakistan, tumor marker technology is not a new one. It...

Effectiveness of weekly iron supplementation in anemia in pregnancy

Iron deficiency has been a serious health issue especially in pregnancy. Various studies now consider daily iron as an excessive source of iron supply. In present study we compare effectiveness of daily verses weekly iro...

Download PDF file
  • EP ID EP87305
  • DOI -
  • Views 203
  • Downloads 0

How To Cite

Shehla Shaheen, Qamaruddin Barakzai, Syed Noor, Mansoor Khan (2011). Alendronate a promising / multi aspect drug in the management of ostoeoporosis. Pakistan Journal of Pharmacology, 28(1), 51-66. https://www.europub.co.uk/articles/-A-87305